PHAR
Pharming Group N.V.
Price Chart
Latest Quote
$12.78
-0.10 (-0.77%)
Current Price
| Previous Close | $12.87 |
| Open | $13.00 |
| Day High | $13.00 |
| Day Low | $12.78 |
| Volume | 4,522 |
Stock Information
| Shares Outstanding | 70.63M |
| Total Debt | $116.20M |
| Cash Equivalents | $170.18M |
| Revenue | $369.49M |
| Net Income | $12.36M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $902.24M |
| P/E Ratio | 67.24 |
| EPS (TTM) | $0.19 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $904.75M |
| Sales | $369.49M |
| Income | $12.36M |
| Book/sh | $3.61 |
| Cash/sh | $2.41 |
| Employees | 407 |
Financial Ratios
| Quick Ratio | 2.05 |
| Current Ratio | 2.63 |
| Debt/Eq | 43.20 |
Returns & Margins
| ROA | 4.89% |
| ROE | 5.04% |
| Gross Margin | 88.14% |
| Operating Margin | -6.78% |
| Profit Margin | 3.34% |
Ownership
| Institutional Ownership | 0.15% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 44.00 |
| P/S | 2.44 |
| P/B | 3.54 |
Analyst Data
| Recommendation | none |
| Target Price | $34.35 |
Technical Indicators
| SMA20 | $12.79 |
| SMA50 | $14.36 |
| SMA200 | $15.67 |
| RSI | 45.21 |
| ATR | 0.5153 |
| Shares Float | 73.29M |
| Short Float | 0.01% |
| Short Ratio | 0.31 |
| Volatility | 0.10 |
| Rel Volume | 0.46 |
Performance History
| Week | -0.23% |
| Month | -0.74% |
| Quarter | -16.83% |
| 6 Months | -23.09% |
| YTD | -25.47% |
| Year | +17.80% |
| 3 Years | +5.49% |
| 5 Years | +5.67% |
| 10 Years | -23.50% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $12.77 | 4,522 |
| 2026-06-18 | $12.87 | 3,300 |
| 2026-06-17 | $12.65 | 1,800 |
| 2026-06-16 | $12.51 | 2,000 |
| 2026-06-15 | $12.81 | 3,600 |
| 2026-06-12 | $12.81 | 6,800 |
| 2026-06-11 | $12.88 | 2,400 |
| 2026-06-10 | $12.28 | 3,900 |
| 2026-06-09 | $12.59 | 4,100 |
| 2026-06-08 | $12.80 | 9,400 |
| 2026-06-05 | $12.54 | 10,800 |
| 2026-06-04 | $12.47 | 11,800 |
| 2026-06-03 | $12.24 | 4,600 |
| 2026-06-02 | $12.28 | 22,600 |
| 2026-06-01 | $13.10 | 11,200 |
| 2026-05-29 | $12.99 | 21,800 |
| 2026-05-28 | $13.66 | 12,100 |
| 2026-05-27 | $13.41 | 4,800 |
| 2026-05-26 | $13.62 | 31,400 |
| 2026-05-22 | $12.60 | 25,500 |
About Pharming Group N.V.
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K? inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
đ° Latest News
DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock?
Zacks âĸ 2026-06-15T11:59:00Z
High Growth Tech Stocks in Europe with Promising Potential
Simply Wall St. âĸ 2026-06-05T05:38:02Z
We Think Pharming Group's (AMS:PHARM) Profit Is Only A Baseline For What They Can Achieve
Simply Wall St. âĸ 2026-05-14T06:09:43Z
Pharming Group N.V. Recorded A 21% Miss On Revenue: Analysts Are Revisiting Their Models
Simply Wall St. âĸ 2026-05-11T04:04:22Z
Pharming Group Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-08T19:12:29Z
High Growth Tech Stocks To Watch In May 2026
Simply Wall St. âĸ 2026-05-05T09:38:39Z
3 European Penny Stocks With Market Caps Over âŦ10M
Simply Wall St. âĸ 2026-04-14T11:05:09Z
Discovering European Penny Stocks: Lemonsoft Oyj And 2 More Promising Picks
Simply Wall St. âĸ 2026-04-13T11:05:01Z
European Penny Stocks To Watch In April 2026
Simply Wall St. âĸ 2026-04-13T06:05:16Z
3 European Penny Stocks With Market Caps Over âŦ30M
Simply Wall St. âĸ 2026-04-10T11:05:13Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $43,493,000 | $28,690,000 | $18,443,000 | $11,528,000 |
| Cost Of Revenue | $45,500,000 | $35,399,000 | $25,212,000 | $17,562,000 |
| Total Revenue | $376,134,000 | $297,200,000 | $245,316,000 | $205,622,000 |
| Operating Revenue | $376,134,000 | $297,200,000 | $245,316,000 | $205,622,000 |
| Expenses | ||||
| Interest Expense | $10,719,000 | $8,737,000 | $5,964,000 | $5,358,000 |
| Total Expenses | $355,253,000 | $300,865,000 | $267,605,000 | $195,762,000 |
| Other Income Expense | $704,000 | $259,000 | $12,712,000 | $10,505,000 |
| Other Non Operating Income Expenses | $1,575,000 | $71,000 | $286,000 | $507,000 |
| Net Non Operating Interest Income Expense | $-8,739,000 | $-5,086,000 | $-2,435,000 | $-5,378,000 |
| Total Other Finance Cost | $196,000 | $1,207,000 | $134,000 | $105,000 |
| Interest Expense Non Operating | $10,719,000 | $8,737,000 | $5,964,000 | $5,358,000 |
| Operating Expense | $309,753,000 | $265,466,000 | $242,393,000 | $178,200,000 |
| Other Operating Expenses | $82,742,000 | $73,742,000 | $76,822,000 | $49,662,000 |
| Selling And Marketing Expense | $6,655,000 | $7,135,000 | $6,817,000 | $6,410,000 |
| General And Administrative Expense | $110,780,000 | $92,081,000 | $80,684,000 | $62,443,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $2,851,000 | $-11,841,000 | $-10,548,000 | $13,674,000 |
| Net Interest Income | $-8,739,000 | $-5,086,000 | $-2,435,000 | $-5,378,000 |
| Interest Income | $2,176,000 | $4,858,000 | $3,663,000 | $85,000 |
| Normalized Income | $3,959,548 | $-13,286,416 | $-21,713,320 | $3,563,798 |
| Net Income From Continuing And Discontinued Operation | $2,851,000 | $-11,841,000 | $-10,548,000 | $13,674,000 |
| Total Operating Income As Reported | $25,842,000 | $-8,621,000 | $-5,387,000 | $18,233,000 |
| Net Income Common Stockholders | $2,851,000 | $-11,841,000 | $-10,548,000 | $13,674,000 |
| Net Income | $2,851,000 | $-11,841,000 | $-10,548,000 | $13,674,000 |
| Net Income Including Noncontrolling Interests | $2,538,000 | $-11,841,000 | $-10,548,000 | $13,674,000 |
| Net Income Continuous Operations | $2,538,000 | $-11,841,000 | $-10,548,000 | $13,674,000 |
| Pretax Income | $12,847,000 | $-8,492,000 | $-12,012,000 | $14,987,000 |
| Special Income Charges | $3,386,000 | $-5,027,000 | $16,616,000 | $7,866,000 |
| Earnings From Equity Interest | $623,000 | $-1,760,000 | $-289,000 | $-1,083,000 |
| Interest Income Non Operating | $2,176,000 | $4,858,000 | $3,663,000 | $85,000 |
| Operating Income | $20,881,000 | $-3,665,000 | $-22,289,000 | $9,860,000 |
| Depreciation Amortization Depletion Income Statement | $9,209,000 | $9,361,000 | $9,156,000 | $7,154,000 |
| Depreciation And Amortization In Income Statement | $9,209,000 | $9,361,000 | $9,156,000 | $7,154,000 |
| Amortization Of Intangibles Income Statement | $6,285,000 | $6,041,000 | $5,635,000 | $4,257,000 |
| Depreciation Income Statement | $2,924,000 | $3,320,000 | $3,521,000 | $2,897,000 |
| Gross Profit | $330,634,000 | $261,801,000 | $220,104,000 | $188,060,000 |
| Per Share | ||||
| Diluted EPS | $0.04 | $-0.16 | $-0.15 | $0.19 |
| Basic EPS | $0.04 | $-0.16 | $-0.15 | $0.21 |
| Other | ||||
| Tax Effect Of Unusual Items | $-385,452 | $502,584 | $1,549,680 | $970,798 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $36,276,000 | $14,367,000 | $-2,838,000 | $22,452,000 |
| Total Unusual Items | $-1,494,000 | $1,948,000 | $12,715,000 | $11,081,000 |
| Total Unusual Items Excluding Goodwill | $-1,494,000 | $1,948,000 | $12,715,000 | $11,081,000 |
| Reconciled Depreciation | $11,216,000 | $16,070,000 | $15,925,000 | $13,188,000 |
| EBITDA (Bullshit earnings) | $34,782,000 | $16,315,000 | $9,877,000 | $33,533,000 |
| EBIT | $23,566,000 | $245,000 | $-6,048,000 | $20,345,000 |
| Diluted Average Shares | $71,275,000 | $68,775,000 | $67,460,000 | $71,968,421 |
| Basic Average Shares | $71,275,000 | $68,775,000 | $67,460,000 | $65,114,286 |
| Diluted NI Availto Com Stockholders | $2,851,000 | $-11,841,000 | $-10,548,000 | $13,674,000 |
| Minority Interests | $313,000 | $0 | $0 | - |
| Tax Provision | $10,310,000 | $3,349,000 | $-1,464,000 | $1,313,000 |
| Gain On Sale Of Ppe | $0 | $0 | $21,279,000 | $0 |
| Other Special Charges | $-3,877,000 | - | - | - |
| Impairment Of Capital Assets | $491,000 | $5,027,000 | $4,663,000 | $4,376,000 |
| Gain On Sale Of Security | $-4,880,000 | $6,975,000 | $-3,901,000 | $3,215,000 |
| Amortization | $6,285,000 | $6,041,000 | $5,635,000 | $4,257,000 |
| Research And Development | $100,367,000 | $83,147,000 | $68,914,000 | $52,531,000 |
| Selling General And Administration | $117,435,000 | $99,216,000 | $87,501,000 | $68,853,000 |
| Other Gand A | $18,274,000 | $17,764,000 | $14,990,000 | $14,717,000 |
| Salaries And Wages | $92,506,000 | $74,317,000 | $65,694,000 | $47,726,000 |
| Gain On Sale Of Business | - | $0 | $0 | $12,242,000 |
| Restructuring And Mergern Acquisition | - | - | - | $0 |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $141,564,000 | $160,022,000 | $147,514,000 | $129,517,000 |
| Total Assets | $499,963,000 | $399,985,000 | $462,854,000 | $425,797,000 |
| Total Non Current Assets | $200,495,000 | $121,545,000 | $146,512,000 | $148,297,000 |
| Other Non Current Assets | $1,228,000 | $1,505,000 | $1,528,000 | $1,099,000 |
| Non Current Prepaid Assets | $94,000 | $90,000 | $92,000 | $228,000 |
| Non Current Deferred Assets | $31,017,000 | $30,544,000 | $29,761,000 | $22,973,000 |
| Non Current Deferred Taxes Assets | $31,017,000 | $30,544,000 | $29,761,000 | $22,973,000 |
| Investmentin Financial Assets | $6,703,000 | $3,767,000 | $8,113,000 | $7,230,000 |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | $6,703,000 | $3,767,000 | $6,093,000 | $6,827,000 |
| Goodwill And Other Intangible Assets | $135,538,000 | $61,039,000 | $71,267,000 | $75,121,000 |
| Other Intangible Assets | $132,219,000 | $61,039,000 | $71,267,000 | $75,121,000 |
| Current Assets | $299,469,000 | $278,440,000 | $316,342,000 | $277,500,000 |
| Other Current Assets | $1,000 | - | - | - |
| Restricted Cash | $761,000 | $0 | $0 | $213,000 |
| Prepaid Assets | $6,263,000 | $4,651,000 | $3,543,000 | $2,288,000 |
| Inventory | $64,902,000 | $55,724,000 | $56,760,000 | $42,326,000 |
| Receivables | $48,441,000 | $50,172,000 | $42,615,000 | $25,331,000 |
| Other Receivables | $1,932,000 | $1,596,000 | $2,145,000 | $1,117,000 |
| Taxes Receivable | $4,742,000 | $7,045,000 | $5,062,000 | $3,250,000 |
| Accounts Receivable | $41,767,000 | $41,531,000 | $35,408,000 | $20,964,000 |
| Cash Cash Equivalents And Short Term Investments | $179,101,000 | $167,893,000 | $213,424,000 | $207,342,000 |
| Cash And Cash Equivalents | $145,305,000 | $54,944,000 | $61,741,000 | $207,342,000 |
| Debt | ||||
| Total Debt | $115,775,000 | $112,313,000 | $171,545,000 | $166,694,000 |
| Long Term Debt And Capital Lease Obligation | $107,070,000 | $105,122,000 | $166,105,000 | $161,461,000 |
| Long Term Debt | $92,719,000 | $78,154,000 | $136,598,000 | $131,618,000 |
| Current Debt And Capital Lease Obligation | $8,705,000 | $7,191,000 | $5,440,000 | $5,233,000 |
| Current Debt | $5,336,000 | $4,245,000 | $1,824,000 | $1,768,000 |
| Other Current Borrowings | $5,336,000 | $4,245,000 | $1,824,000 | $1,768,000 |
| Net Debt | - | $27,455,000 | $76,681,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $222,861,000 | $178,924,000 | $244,073,000 | $221,159,000 |
| Total Non Current Liabilities Net Minority Interest | $107,070,000 | $105,122,000 | $166,105,000 | $161,461,000 |
| Current Liabilities | $115,791,000 | $73,802,000 | $77,968,000 | $59,698,000 |
| Other Current Liabilities | $-1,000 | - | - | - |
| Payables And Accrued Expenses | $105,900,000 | $66,611,000 | $72,528,000 | $54,465,000 |
| Payables | $14,588,000 | $13,387,000 | $22,256,000 | $10,852,000 |
| Total Tax Payable | $6,043,000 | $3,284,000 | $6,234,000 | $2,099,000 |
| Accounts Payable | $8,545,000 | $10,103,000 | $16,022,000 | $8,753,000 |
| Other Non Current Liabilities | - | - | - | - |
| Other Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $277,102,000 | $221,061,000 | $218,781,000 | $204,638,000 |
| Total Equity Gross Minority Interest | $277,102,000 | $221,061,000 | $218,781,000 | $204,638,000 |
| Stockholders Equity | $277,102,000 | $221,061,000 | $218,781,000 | $204,638,000 |
| Gains Losses Not Affecting Retained Earnings | $28,819,000 | $-209,000 | $-2,057,000 | $-8,737,000 |
| Other Equity Adjustments | $28,819,000 | $-209,000 | $-2,057,000 | $-8,737,000 |
| Retained Earnings | $-272,983,000 | $-275,489,000 | $-265,262,000 | $-256,431,000 |
| Long Term Equity Investment | $1,944,000 | $466,000 | $2,285,000 | $2,501,000 |
| Investments In Other Ventures Under Equity Method | - | - | - | $2,501,000 |
| Other | ||||
| Ordinary Shares Number | $701,680,440 | $680,308,735 | $671,073,243 | $656,348,225 |
| Share Issued | $701,680,440 | $680,308,735 | $671,073,243 | $656,348,225 |
| Tangible Book Value | $141,564,000 | $160,022,000 | $147,514,000 | $129,517,000 |
| Invested Capital | $375,157,000 | $303,460,000 | $357,203,000 | $338,024,000 |
| Working Capital | $183,678,000 | $204,638,000 | $238,374,000 | $217,802,000 |
| Capital Lease Obligations | $17,720,000 | $29,914,000 | $33,123,000 | $33,308,000 |
| Total Capitalization | $369,821,000 | $299,215,000 | $355,379,000 | $336,256,000 |
| Minority Interest | $0 | $0 | - | - |
| Additional Paid In Capital | $513,257,000 | $488,990,000 | $478,431,000 | $462,297,000 |
| Capital Stock | $8,009,000 | $7,769,000 | $7,669,000 | $7,509,000 |
| Common Stock | $8,009,000 | $7,769,000 | $7,669,000 | $7,509,000 |
| Long Term Capital Lease Obligation | $14,351,000 | $26,968,000 | $29,507,000 | $29,843,000 |
| Current Capital Lease Obligation | $3,369,000 | $2,946,000 | $3,616,000 | $3,465,000 |
| Current Provisions | $1,187,000 | - | - | - |
| Current Accrued Expenses | $91,312,000 | $53,224,000 | $50,272,000 | $43,613,000 |
| Investments And Advances | $8,647,000 | $4,233,000 | $10,398,000 | $9,731,000 |
| Investmentsin Associatesat Cost | $1,944,000 | $466,000 | $2,285,000 | - |
| Goodwill | $3,319,000 | $0 | - | - |
| Net PPE | $23,971,000 | $24,134,000 | $33,466,000 | $39,145,000 |
| Accumulated Depreciation | $-36,428,000 | $-29,949,000 | $-26,931,000 | $-19,989,000 |
| Gross PPE | $60,399,000 | $54,083,000 | $60,397,000 | $59,134,000 |
| Leases | $6,403,000 | $5,432,000 | $5,546,000 | $5,282,000 |
| Construction In Progress | $0 | $145,000 | $179,000 | $6,000 |
| Other Properties | $6,115,000 | $5,384,000 | $5,131,000 | $4,691,000 |
| Machinery Furniture Equipment | $19,935,000 | $18,588,000 | $18,582,000 | $16,271,000 |
| Buildings And Improvements | $27,946,000 | $24,534,000 | $30,959,000 | $32,884,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $18,214,000 | $16,297,000 | $18,349,000 | $12,460,000 |
| Work In Process | $46,688,000 | $39,002,000 | $37,706,000 | $29,553,000 |
| Raw Materials | $0 | $425,000 | $705,000 | $313,000 |
| Other Short Term Investments | $33,796,000 | $112,949,000 | $151,683,000 | $0 |
| Available For Sale Securities | - | - | $2,020,000 | $403,000 |
| Land And Improvements | - | - | $0 | $0 |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $53,953,000 | $-2,591,000 | $-18,766,000 | $20,481,000 |
| Operating Activities | ||||
| Operating Cash Flow | $54,708,000 | $-1,795,000 | $-17,302,000 | $22,458,000 |
| Cash Flow From Continuing Operating Activities | $54,708,000 | $-1,795,000 | $-17,302,000 | $22,458,000 |
| Operating Gains Losses | $-4,356,000 | $1,780,000 | $-20,990,000 | $-11,159,000 |
| Investing Activities | ||||
| Capital Expenditure | $-755,000 | $-796,000 | $-1,464,000 | $-1,977,000 |
| Investing Cash Flow | $26,252,000 | $31,618,000 | $-129,388,000 | $5,323,000 |
| Cash Flow From Continuing Investing Activities | $26,253,000 | $31,618,000 | $-129,388,000 | $5,323,000 |
| Net Other Investing Changes | $-1,000 | - | $21,279,000 | - |
| Capital Expenditure Reported | $-749,000 | $-790,000 | $-1,437,000 | $-1,376,000 |
| Financing Activities | ||||
| Financing Cash Flow | $1,495,000 | $-34,412,000 | $-1,039,000 | $-4,982,000 |
| Cash Flow From Continuing Financing Activities | $1,495,000 | $-34,412,000 | $-1,039,000 | $-4,982,000 |
| Net Other Financing Charges | $-7,876,000 | - | - | - |
| Cash Dividends Paid | $0 | $0 | $0 | $0 |
| Issuance Of Capital Stock | - | - | - | $2,281,000 |
| Net Common Stock Issuance | - | - | - | $2,281,000 |
| Common Stock Issuance | - | - | - | $2,281,000 |
| Other | ||||
| Repayment Of Debt | $-4,245,000 | $-138,932,000 | $-4,038,000 | $-3,311,000 |
| Issuance Of Debt | $0 | $104,539,000 | $0 | $0 |
| End Cash Position | $145,305,000 | $54,944,000 | $61,741,000 | $207,342,000 |
| Beginning Cash Position | $54,944,000 | $61,741,000 | $207,342,000 | $191,924,000 |
| Effect Of Exchange Rate Changes | $7,907,000 | $-2,208,000 | $2,128,000 | $-7,381,000 |
| Changes In Cash | $82,454,000 | $-4,589,000 | $-147,729,000 | $22,799,000 |
| Interest Paid Cff | $-6,197,000 | $-5,598,000 | $-5,134,000 | $-3,952,000 |
| Proceeds From Stock Option Exercised | $19,813,000 | $5,579,000 | $8,133,000 | $2,281,000 |
| Net Issuance Payments Of Debt | $-4,245,000 | $-34,393,000 | $-4,038,000 | $-3,311,000 |
| Net Long Term Debt Issuance | $-4,245,000 | $-34,393,000 | $-4,038,000 | $-3,311,000 |
| Long Term Debt Payments | $-4,245,000 | $-138,932,000 | $-4,038,000 | $-3,311,000 |
| Long Term Debt Issuance | $0 | $104,539,000 | $0 | $0 |
| Net Investment Purchase And Sale | $85,223,000 | $32,414,000 | $-149,203,000 | $0 |
| Sale Of Investment | $85,225,000 | $316,728,000 | $232,811,000 | $0 |
| Purchase Of Investment | $-2,000 | $-284,314,000 | $-382,014,000 | $0 |
| Net Business Purchase And Sale | $-58,215,000 | $0 | $0 | $7,300,000 |
| Purchase Of Business | $-58,215,000 | $0 | $0 | - |
| Net Intangibles Purchase And Sale | $-6,000 | $-6,000 | $-27,000 | $-601,000 |
| Purchase Of Intangibles | $-6,000 | $-6,000 | $-27,000 | $-601,000 |
| Taxes Refund Paid | $-4,599,000 | $-15,584,000 | $-655,000 | $-1,235,000 |
| Interest Received Cfo | $2,069,000 | $5,201,000 | $2,883,000 | $85,000 |
| Change In Working Capital | $10,385,000 | $-10,072,000 | $-16,961,000 | $-387,000 |
| Change In Other Working Capital | $902,000 | $-17,000 | $-216,000 | $273,000 |
| Change In Payables And Accrued Expense | $14,126,000 | $-2,769,000 | $16,228,000 | $11,992,000 |
| Change In Payable | $14,126,000 | $-2,769,000 | $16,228,000 | $11,992,000 |
| Change In Inventory | $-1,288,000 | $-503,000 | $-14,434,000 | $-15,016,000 |
| Change In Receivables | $-3,355,000 | $-6,783,000 | $-18,539,000 | $2,364,000 |
| Other Non Cash Items | $13,380,000 | $-1,946,000 | $5,257,000 | $587,000 |
| Stock Based Compensation | $13,766,000 | $11,248,000 | $9,251,000 | $6,392,000 |
| Depreciation Amortization Depletion | $11,216,000 | $16,070,000 | $15,925,000 | $13,188,000 |
| Depreciation And Amortization | $11,216,000 | $16,070,000 | $15,925,000 | $13,188,000 |
| Depreciation | $11,216,000 | $16,070,000 | $15,925,000 | $13,188,000 |
| Earnings Losses From Equity Investments | $-623,000 | $1,758,000 | $289,000 | $1,083,000 |
| Gain Loss On Investment Securities | $-2,345,000 | $-4,990,000 | $930,000 | $1,185,000 |
| Net Income From Continuing Operations | $12,847,000 | $-8,492,000 | $-12,012,000 | $14,987,000 |
| Sale Of Business | - | $0 | $0 | $7,300,000 |
| Gain Loss On Sale Of PPE | - | $22,000 | $0 | $0 |
| Gain Loss On Sale Of Business | - | $0 | $0 | $-12,242,000 |
Fetched: 2026-06-22